Search research articles
Contact Us
Filters
Showing results (441-450 of 457) with videos related to
Page
of 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group
A Bamias, G Aravantinos, C Deliveliotis, et al.
Human Genomics
|
June 21, 2015
Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach
Ioannis Karageorgos, Clint Mizzi, Efstathia Giannopoulou, et al.
Cancer Medicine
|
March 24, 2016
Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis
Aristotle Bamias, Petros Tsantoulis, Thomas Zilli, et al.
Anti-Cancer Drugs
|
October 1, 2015
Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group
Nikolaos Pistamaltzian, Kimon Tzannis, Vassiliki Pissanidou, et al.
Current Oncology (Toronto, Ont.)
|
January 24, 2025
Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette-Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from Six Hospital Centers in Greece
Panagiotis Angelopoulos, Titos Markopoulos, Lazaros Lazarou, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group
Aristotelis Bamias, Konstantinos Koutsoukos, Nikos Gavalas, et al.
Journal of Visualized Experiments : Jove
|
June 2, 2020
A Salt-Templated Synthesis Method for Porous Platinum-based Macrobeams and Macrotubes
F John Burpo, Anchor R Losch, Enoch A Nagelli, et al.
World Journal of Urology
|
July 11, 2016
Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients
Michalis Liontos, Eleni-Andriana Trigka, Penelope Korkolopoulou, et al.
Annals of the Rheumatic Diseases
|
July 11, 2023
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
Ioannis Parodis, Charlotte Girard-Guyonvarc'h, Laurent Arnaud, et al.
Current Oncology (Toronto, Ont.)
|
September 22, 2022
Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study
Aristotelis Bamias, Kimon Tzannis, Roubini Zakopoulou, et al.
Page
of 46
Search research articles
Search
Showing results (441-450 of 457) with videos related to
Sort By:
Page
of 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group
A Bamias, G Aravantinos, C Deliveliotis, et al.
Human Genomics
|
June 21, 2015
Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach
Ioannis Karageorgos, Clint Mizzi, Efstathia Giannopoulou, et al.
Cancer Medicine
|
March 24, 2016
Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis
Aristotle Bamias, Petros Tsantoulis, Thomas Zilli, et al.
Anti-Cancer Drugs
|
October 1, 2015
Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group
Nikolaos Pistamaltzian, Kimon Tzannis, Vassiliki Pissanidou, et al.
Current Oncology (Toronto, Ont.)
|
January 24, 2025
Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette-Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from Six Hospital Centers in Greece
Panagiotis Angelopoulos, Titos Markopoulos, Lazaros Lazarou, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group
Aristotelis Bamias, Konstantinos Koutsoukos, Nikos Gavalas, et al.
Journal of Visualized Experiments : Jove
|
June 2, 2020
A Salt-Templated Synthesis Method for Porous Platinum-based Macrobeams and Macrotubes
F John Burpo, Anchor R Losch, Enoch A Nagelli, et al.
World Journal of Urology
|
July 11, 2016
Expression and prognostic significance of VEGF and mTOR pathway proteins in metastatic renal cell carcinoma patients: a prognostic immunohistochemical profile for kidney cancer patients
Michalis Liontos, Eleni-Andriana Trigka, Penelope Korkolopoulou, et al.
Annals of the Rheumatic Diseases
|
July 11, 2023
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
Ioannis Parodis, Charlotte Girard-Guyonvarc'h, Laurent Arnaud, et al.
Current Oncology (Toronto, Ont.)
|
September 22, 2022
Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study
Aristotelis Bamias, Kimon Tzannis, Roubini Zakopoulou, et al.
Page
of 46